Alveolar soft part sarcomas: Molecular pathogenesis and implications for novel targeted therapies

24Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Alveolar soft part sarcoma (ASPS) is a very rare soft tissue sarcoma which arises primarily in children and young adults. Despite its unique histology and well-characterized genetic translocation, many questions remain regarding the pathogenesis and treatment of this tumor type. Though collective clinical experience with this tumor type spans more than 60 years, there has been little progress made in treating this uncommon but frequently fatal disease. This paper focuses on the available data regarding its molecular pathogenesis and insights into targeted therapeutics as well as the results of clinical trials performed to date to hopefully improve the outcome of patients with this rare malignancy. Copyright 2012 Bryan Mitton and Noah Federman.

Cite

CITATION STYLE

APA

Mitton, B., & Federman, N. (2012). Alveolar soft part sarcomas: Molecular pathogenesis and implications for novel targeted therapies. Sarcoma. https://doi.org/10.1155/2012/428789

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free